Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Spacer
Accretion Nutraveda Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544694 INE1KVQ01019 48.9961326 Not Listed 0 208.51 0 0 10
Your Result on : Markets | Equity | Corporate Information | Profit & Loss
     ParticularsMar 2026
(Rs.Cr)
Mar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
INCOME :    
Sales Turnover 33.6016.005.012.90
Excise Duty0.000.000.000.00
Net Sales33.6016.005.012.90
Other Income 0.110.010.190.17
Stock Adjustments 0.960.951.300.00
Total Income34.6716.966.503.07
EXPENDITURE :    
Raw Materials 25.0711.524.161.70
Power & Fuel Cost0.140.110.090.04
Employee Cost 0.500.230.180.10
Other Manufacturing Expenses 0.810.640.320.17
Selling & Administrative Expenses 1.100.710.320.27
Miscellaneous Expenses 0.050.020.010.00
Less : Pre-operative Expenses Capitalised 0.000.000.000.00
Total Expenditure27.6813.235.082.28
Operating Profit7.003.721.420.79
Interest 0.530.350.240.19
Gross Profit6.473.371.180.60
Depreciation0.260.220.260.31
Profit Before Tax6.213.150.920.29
Tax1.140.650.100.00
Fringe Benefit tax0.000.000.000.00
Deferred Tax0.000.00-0.010.01
Reported Net Profit5.072.500.820.28
Extraordinary Items 0.000.000.000.00
Adjusted Net Profit5.072.500.820.28
Adjustment below Net Profit -2.720.000.000.00
P & L Balance brought forward3.040.54-0.10-0.38
Statutory Appropriations0.000.000.000.00
Appropriations 0.000.000.000.00
P & L Balance carried down5.393.040.72-0.10
Dividend0.000.000.000.00
Preference Dividend0.000.000.000.00
Equity Dividend %0.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.00
Earnings Per Share-Unit Curr7.0051.3522.837.79
Earnings Per Share(Adj)-Unit Curr7.0051.3522.837.79
Book Value-Unit Curr49.00103.7430.147.31
Book Value(Adj)-Unit Curr49.00103.7430.147.31
Spacer